ATAI
AtaiBeckley is a biotechnology company focused on developing mental health treatments with patient-centric, evidence-based approaches. The company aims to transform outcomes by delivering rapid-acting and convenient therapies for mental health conditions, pursuing a broad pipeline and therapeutic areas. It emphasizes clinical research, collaboration, and leadership in drug development to address global mental health needs and improve access to effective care.
No recent deals for this company.